TG Therapeutics Inc — Cash Flow (NASDAQ:TGTX) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities 214.51 M295.63 M176.17 M31.41 M40.52 M 70.07 M Cash from investing activities 24.51 M332 K20.01 M50.65 M1.04 M 13.65 M Cash from financing activities 679.83 M41.42 M391 K72.7 M128.53 M 84.72 M Free cash flow 214.15 M295.23 M176.16 M31.41 M40.47 M 69.91 M

Новости

TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line

TG Therapeutics (TGTX) Misses Q4 Earnings Estimates

TG: доходы оказались ниже прогнозов, прибыльa обогнал ожидания в Q4

TG earnings missed by $0.23, revenue topped estimates

Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates

TG Therapeutics faces earnings test as Briumvi growth accelerates

TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release

TG Therapeutics представляет данные о BRIUMVI на форуме ACTRIMS

TG Therapeutics presents BRIUMVI data at ACTRIMS forum

TG Therapeutics сохраняет рейтинг "Покупать" от B.Riley

TG Therapeutics stock maintains Buy rating at B.Riley on strong Briumvi growth

TG Therapeutics представит данные о BRIUMVI на форуме ACTRIMS